Fundamental Analysis
30 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -76.0% | +33.0% | 1 / 3 | -13.1% | -0.19 pp | -1.56 pp | +4.4% | 0.78 | 40.81 | 326 | −13,1% | 1,9 | −76,0% | 40.81 | 23.86 | +71,1% |
| Pts | 0 | 4 | 4 | 0 | 4 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 36.000 (close price on 2026-10-19)EPS (TTM): 882,1
Financial charts
1.Revenue & growth
VND bn326Q2/26
1.Revenue & growth
VND bn326Q2/26
2.Profit & growth
VND bn1,94Q2/26
3.Profit mix (Penman)
VND bn32,2Q2/26
4.Margins & cost structure
%9.8%Q2/26
5.Returns & cash cycle
% · days4.2%Q2/26
6.Earnings quality & cash
VND bn-53,0Q2/26
7.Asset structure
VND bn1.236Q2/26
8.Funding & debt health
VND bn · times1.236Q2/26
9.Revenue backlog
VND bn12,6Q2/26
10.Valuation
times · %52,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %53Q2/26
Adjusted EPS growth, latest quarter
-76.0%
Average adjusted EPS growth, 3 quarters
33.0%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
-0.0%
Source: vnstockData through Q2/26